Loading clinical trials...
Loading clinical trials...
A Randomized Double-blinded Controlled Trial Comparing Dilation and Evacuation Outcomes With and Without Oxytocin Use
Currently, there is very little research to identify ways to decrease blood loss during D\&E (dilation and evacuation) procedures. The objective is to determine whether routine use of intravenous oxytocin will improve bleeding outcomes at the time of D\&E at 18-24-weeks gestation. To evaluate the hypothesis, investigators will perform a randomized, double-blinded, placebo-controlled trial. The patient will be followed until discharged from the postoperative care unit during which time patient satisfaction, pain score and postoperative bleeding will be assessed.
Age
14 - 50 years
Sex
FEMALE
Healthy Volunteers
No
University of Hawaii
Honolulu, Hawaii, United States
University of Washington
Seattle, Washington, United States
Start Date
October 1, 2014
Primary Completion Date
February 1, 2018
Completion Date
February 1, 2018
Last Updated
November 27, 2020
166
ACTUAL participants
intravenous oxytocin
DRUG
Intravenous Fluids and Electrolytes
DRUG
Lead Sponsor
University of Hawaii
Collaborators
NCT05548530
NCT07466719
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07458880